Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACE: Rivaroxaban vs Aspirin in TIA or Minor Stroke
NCT01923818Phase 3Unknown
- Sponsor
- Xijing Hospital
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in Transient Ischemic Attack (TIA), ischemic stroke, sponsored by Xijing Hospital. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Transient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT01923818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923818.